Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 800-826-4673
Summary
- Dr. Hannah Lu is an Internal Medicine specialist practicing in Dallas, TX. She earned her MD from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2018. She then completed her residency in Internal Medicine at the University of Texas Southwestern Medical Center from 2018 to 2021. Additionally, Dr. Lu holds a Bachelor's degree in Economics from Northwestern University. She has worked as a Research Associate at City of Hope's Helford Clinical Research Hospital. Dr. Lu has also contributed to the medical field with multiple published and cited research articles appearing in reputed publications like In Vivo, Clinical Cancer Research, Toxicological Sciences, Breast Cancer Research and Treatment, and Leukemia.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2018 - 2021- University of Texas Southwestern Medical CenterInternship, Internal Medicine, 2018 - 2019
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2018, MD
Northwestern UniversityBachelor of Arts, Economics, 2009 - 2013
Certifications & Licensure
CA State Medical License 2024 - 2026
TX State Medical License 2021 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsOsimertinib in Pulmonary Manifestations: Two Case Reports and Review of the Literature.Hannah Lu, Jonathan E. Dowell
In Vivo. 2020-01-01 - 23 citationsAlternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.Hrishikesh M. Mehta, Muneyoshi Futami, Taly Glaubach, Daniel W. Lee, Jeffrey R. Andolina
Leukemia. 2014-05-01 - 26 citationsGranulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.Hrishikesh M. Mehta, Taly Glaubach, A. Long, Hannah Lu, Bartlomiej P Przychodzen
Leukemia. 2013-06-06
Press Mentions
College Campuses Emerging as ‘COVID-19 Super-Spreaders,’ Infecting Surrounding TownsFebruary 12th, 2021- Research Reveals Alarming Rates of COVID-19 Transmission in CollegesJanuary 15th, 2021
- Are Colleges Covid-19 Superspreaders? Cases Went up by 56% in Counties Where Classes Were in Person, Says CDCJanuary 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
